The Monday After the Deal Closes

Kinderhook Industries' $1.1 billion acquisition of Enhabit is the kind of deal that generates a lot of confident analysis about what comes next — value-based care acceleration, technology investment, platform expansion. The thesis is compelling. The capital is real. The strategic intent seems genuine.

I spent over a decade operating inside home health. And when I read deal coverage like this, I find myself thinking less about the investment thesis and more about what happens the Monday after the deal closes.

Because home health is not a SaaS platform. It does not scale on a spreadsheet.

Home health runs on clinicians. Not infrastructure. Not technology. Physical therapists, occupational therapists, skilled nurses — people who get in their cars, drive to someone's home, and deliver care alone. Every unit of revenue this business generates exists because a clinician showed up at a door.

When that clinician leaves, the visit doesn't get rescheduled by a system. It gets absorbed by someone who's already stretched, covered by a contract clinician at a cost premium that would make your eyes water, or it just doesn't happen. And when visits don't happen, census drops. When census drops, the remaining staff notices. And then they start making career decisions.

Contract labor is the industry's answer to the acute version of this problem. It works — right up until it stops being a bridge and starts being the foundation. At that point you've got a cost structure that's almost impossible to unwind without operational investment that most deal models never penciled in.

The platforms that manage this well don't treat clinicians like a variable cost. They treat the workforce as the asset. That distinction sounds philosophical until you're staring at a market that's bleeding visits.

Home Health Value-Based Purchasing creates a direct line between how care gets delivered and what Medicare pays you. That line doesn't care about your acquisition timeline.

Here's how it actually plays out: the disruption that comes with any deal — leadership changes, workflow uncertainty, staff anxiety — doesn't show up in your quality metrics immediately. It shows up twelve to eighteen months later, when the episodes delivered during that turbulent stretch get scored. By then the integration is "done." The prior leadership has moved on. And the reimbursement adjustment lands like a bill you forgot you ran up.

Star ratings make it worse. Referral sources — hospitals, discharge planners, physician practices, managed care organizations — use those ratings. A provider that drops from four stars to three during an integration year doesn't just lose reimbursement. It loses the referral relationships that took years to build. And those don't come back just because operations stabilized.

That's not a problem that resolves on its own. It's a cycle. Breaking it requires someone who understands it before the deal closes — not someone who discovers it six quarters later wondering why the model isn't performing.

The platforms that actually deliver on the value-based care promise won't be the ones that raised the most money. They'll be the ones that understood the operational physics of this business before they wrote the check — and treated workforce infrastructure and quality management as the investment, not the overhead.